INTERNATIONAL PATENT: JOHNSON & JOHNSON ENTERPRISE INNOVATION INC., JOHNSON & JOHNSON (CHINA) INVESTMENT LTD. FILES APPLICATION FOR "CRYSTALLINE FORMS OF A2A RECEPTOR ANTAGONIST, PREPARATION METHODS AND USES THEREOF"

GENEVA, June 20 -- JOHNSON & JOHNSON ENTERPRISE INNOVATION INC. (One Johnson & Johnson Plaza, New BrunswickNew Jersey 08933), JOHNSON & JOHNSON (CHINA) INVESTMENT LTD. (2101, No.1 Building, 65 Gui Qing RoadXuhui District, Shanghai 200233) filed a patent application (PCT/CN2023/138508) for "CRYSTALLINE FORMS OF A2A RECEPTOR ANTAGONIST, PREPARATION METHODS, AND USES THEREOF" on Dec 13, 2023. With publication no. WO/2025/123251, the details related to the patent application was published on Jun 19, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): NG, Alicia (Johnson & Johnson (China) Investment ...